Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies

Successful adoptive chimeric antigen receptor (CAR) T-cell therapies against hematological malignancies require CAR-T expansion and durable persistence following infusion. Balancing increased CAR-T potency with safety, including severe cytokine-release syndrome (sCRS) and neurotoxicity, warrants inc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Leukemia
Autors principals: Collinson-Pautz, Matthew R., Chang, Wei-Chun, Lu, An, Khalil, Mariam, Crisostomo, Jeannette W., Lin, Pei-Yi, Mahendravada, Aruna, Shinners, Nicholas P., Brandt, Mary E., Zhang, Ming, Duong, MyLinh, Bayle, J. Henri, Slawin, Kevin M., Spencer, David M., Foster, Aaron E.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6756044/
https://ncbi.nlm.nih.gov/pubmed/30816327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-019-0417-9
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars